GS
BDMDW

GTS Securities’s Baird Medical Investment Holdings Warrant BDMDW Stock Holding History

GTS Securities’s Portfolio BDMDW Stock Details BDMDW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$414 Buy
+10,098
New +$634 ﹤0.01% 1316

Other funds holding BDMDW

SC
Sculptor Capital New York $12.3B AUM 40.26% 1-Year Est. Return
CS
Clear Street New York $39.5B AUM 124.03% 1-Year Est. Return
AC
Aristeia Capital Greenwich, Connecticut $7.69B AUM 15.48% 1-Year Est. Return
Calamos Advisors
Calamos Advisors Naperville, Illinois $30.1B AUM 30.03% 1-Year Est. Return
LA
Linden Advisors New York $19.3B AUM 1.47% 1-Year Est. Return
KC
Kepos Capital New York $73.4M AUM 4.78% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return
DKCM
Davidson Kempner Capital Management New York $8.42B AUM 61.81% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Toronto Dominion Bank
Toronto Dominion Bank Toronto, Ontario, Ontario, Canada $86.4B AUM 59.51% 1-Year Est. Return

GTS Securities's BDMDW Position: Q2 2026 in Review

GTS Securities opened a new position in Baird Medical Investment Holdings Warrant (BDMDW) in Q2 2026: 10,098 shares worth $414. The stake represents ﹤0.01% of the portfolio and ranks #1316 among its holdings.

29 funds tracked by Wall St. Rank hold BDMDW as of Q2 2026.

  • GTS Securities held 10,098 shares of Baird Medical Investment Holdings Warrant worth $414 as of Q2 2026.
  • Baird Medical Investment Holdings Warrant was a new GTS Securities position in Q2 2026.
  • Baird Medical Investment Holdings Warrant made up ﹤0.01% of GTS Securities's portfolio in Q2 2026, its #1316 holding.
  • 29 funds tracked by Wall St. Rank held Baird Medical Investment Holdings Warrant as of Q2 2026.

Based on GTS Securities's 13F filing for Q2 2026, filed 14 Aug 2026.